At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 125 enrolled
Drug / intervention
Ketorolac +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal
University of Texas Southwestern Medical Center·interventional·Posted Oct 2, 2019·Updated Jan 10, 2024
In Brief
A Phase 2 clinical trial evaluating Ketorolac and normal saline for Pain and 2 related conditions. Completed, enrolled 125 participants across 1 site.
Detailed Summary
This is a prospective randomized double-blind controlled trial assessing the benefits of intramuscular ketorolac before or immediately after office ureteral stent removal.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Urinary Stone, Urinary Calculi
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20192020202120222023202420252026
Enrollment StartJun 2018
Primary CompletionJun 2019
Study CompletionAug 2019
First PostedOct 2019
TodayJul 2026
First PostedOct 2, 2019
Enrollment StartJun 28, 2018
Primary CompletionJun 30, 2019
Study CompletionAug 30, 2019
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 6.8 years ago
Interventions
Ketorolacdrug
IM injection of either normal saline or Ketorolac
normal salinedrug
normal saline